Bottom line
JDOC vs QAAGZX: the short answer
JDOC (JPMorgan Healthcare Leaders ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 58% by weight.
But QAAGZX is far broader, holding 277 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 0.86% — a difference of $21 a year per $10,000 invested.
Over one year, QAAGZX returned +18.1% vs +14.9% for JDOC.
Updated Nov 19, 2026
JDOC vs QAAGZX side by side
| JDOC | QAAGZX | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | J.P. Morgan | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.65% | 0.86% |
| Annual cost per $10k | $65 | $86 |
| 10-yr cost on $10k (prospectus) | $810 | $1,061 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +14.9% | +18.1% |
| 5-yr return (annualized) | — | +4.1% |
| 10-yr return (annualized) | — | +9.0% |
| Best quarter | +11.3% | +23.4% |
| Worst quarter | −11.9% | −15.8% |
| Net assets (fund) | $9.1M | $751.7M |
| Number of holdings | 61 | 277 |
| Portfolio turnover | 92% | 65% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JDOC | QAAGZX | Difference |
|---|---|---|---|
| 2025 | +14.9% | +18.1% | −3.2% |
| 2024 | −0.6% | +1.7% | −2.3% |
Source: Fund prospectus bar charts
Holdings overlap
13 of JDOC's top 25 holdings also appear in QAAGZX's top 25.
| Holding | JDOC | QAAGZX |
|---|---|---|
| AbbVie, Inc. | 7.85% | 5.12% |
| Eli Lilly & Co. | 7.76% | 14.06% |
| UnitedHealth Group, Inc. | 5.85% | 5.88% |
| Merck & Co., Inc. | 4.82% | 4.00% |
| Johnson & Johnson | 4.82% | 6.64% |
| Thermo Fisher Scientific, Inc. | 3.73% | 2.53% |
| Bristol-Myers Squibb Co. | 3.57% | 2.12% |
| Abbott Laboratories | 3.11% | 1.91% |
| CVS Health Corp. | 2.83% | 0.93% |
| Stryker Corp. | 2.23% | 1.78% |
| Danaher Corp. | 2.16% | 1.44% |
| Intuitive Surgical, Inc. | 1.93% | 1.89% |
| Cardinal Health, Inc. | 1.51% | 1.04% |
Source: SEC Form N-PORT
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between JDOC and QAAGZX?
Which is cheaper, JDOC or QAAGZX?
Should I own both JDOC and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.